Pfizer : PFE

All Pfizer Articles

1518 Articles

Jon C. Ogg | Mar 6, 2015 at 12:20 PM EST

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

With AT&T dropped from the Dow in favor of Apple, investors may be wondering which Dow stocks could get booted…

Lee Jackson | Mar 5, 2015 at 9:20 AM EST

5 Stocks Just Added to Credit Suisse Top Picks List

Here are five new members of the Credit Suisse Top Picks list in five separate market sectors. They look poised…

Trey Thoelcke | Feb 26, 2015 at 11:35 AM EST

The 5 NYSE Stocks With the Highest Short Interest in February

Frank Golhen, via Wikimedia CommonsSurges in short interest between the January 30 and February 13 settlement dates lifted Pfizer and…

Lee Jackson | Feb 24, 2015 at 9:10 AM EST

Merrill Lynch Dividend Yield Stocks to Buy

We combined two Merrill Lunch ideas that secular contrarians should be long, or own now, and screened the firm's stocks…

Lee Jackson | Feb 23, 2015 at 9:05 AM EST

Jefferies 4 Top Pharmaceutical Stocks to Buy

One area that makes sense for growth investors is the large cap pharmaceuticals. Here are some the top pharmaceutical stocks…

Paul Ausick | Feb 10, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the DJIA on Tuesday

thinkstockFebruary 10, 2015: Markets opened higher on Tuesday as every sector except energy and basic materials posted solid gains on…

Jon C. Ogg | Feb 9, 2015 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Alcoa, Apple, Deckers, Dish, Pfizer, Petrobras and More

Monday's top analyst upgrades, downgrades and initiations include AbbVie, Alcoa, Apple, Deckers Outdoor, Dish Network, Pfizer and Petrobras.

Paul Ausick | Feb 5, 2015 at 4:01 PM EST

The 4 Stocks That Dominated the DJIA on Thursday

thinkstockFebruary 5, 2015: Markets opened higher on Thursday on news that the Bank of Greece would continue to be able…

Lee Jackson | Feb 5, 2015 at 10:00 AM EST

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the…

Douglas A. McIntyre | Jan 29, 2015 at 6:55 AM EST

Facebook Still a Small Company

Amidst the excitement about Facebook's nearly 50% revenue growth rate and its successful, accelerating movement into mobile, something is lost.

Chris Lange | Jan 27, 2015 at 8:20 AM EST

Pfizer Faces Reality Check With Earnings

Pfizer reported better-than-expected fourth-quarter earnings Tuesday before the U.S. markets opened.

Paul Ausick | Jan 18, 2015 at 8:20 AM EST

Merck Is Top DJIA Stock in 2015

Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year…

Paul Ausick | Jan 13, 2015 at 4:01 PM EST

The 4 Stocks That Weighed on the Market Tuesday

thinkstockJanuary 13, 2015: Markets opened higher again on Tuesday but stocks drifted lower all day and finally broke through into…

Jon C. Ogg | Jan 9, 2015 at 11:25 AM EST

The Bullish and Bearish Case for Pfizer in 2015

One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night…

Jon C. Ogg | Jan 8, 2015 at 8:15 AM EST

The Bullish and Bearish Case for Johnson & Johnson in 2015

One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have…

1 … 63 64 65 66 67 … 102

Pfizer : PFE

All Pfizer Articles

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

5 Stocks Just Added to Credit Suisse Top Picks List

The 5 NYSE Stocks With the Highest Short Interest in February

Merrill Lynch Dividend Yield Stocks to Buy

Jefferies 4 Top Pharmaceutical Stocks to Buy

The 4 Stocks That Lifted the DJIA on Tuesday

Top Analyst Upgrades and Downgrades: AbbVie, Alcoa, Apple, Deckers, Dish, Pfizer, Petrobras and More

The 4 Stocks That Dominated the DJIA on Thursday

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

Facebook Still a Small Company

Pfizer Faces Reality Check With Earnings

Merck Is Top DJIA Stock in 2015

The 4 Stocks That Weighed on the Market Tuesday

The Bullish and Bearish Case for Pfizer in 2015

The Bullish and Bearish Case for Johnson & Johnson in 2015

Forget Gold: For Retirees, This TIPS ETF Fights Inflation Better

UCOP: A 2X Bet on the Metal the World Can’t Electrify Without

After Comparing Every Covered Call Nasdaq-100 ETF These 3 Pay Up to 14 Percent Without Capping Your AI Upside

Medicare Will Split Your $2,100 Drug Bill Into Monthly Installments. You Have to Ask First.

A 72-Year-Old Couple With $900,000 in IRAs Converts Nothing. Their Kids Inherit the Tax Bill Instead.

Forget Gold: For Retirees, This TIPS ETF Fights Inflation Better

UCOP: A 2X Bet on the Metal the World Can’t Electrify Without

Pfizer : PFE

All Pfizer Articles

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

5 Stocks Just Added to Credit Suisse Top Picks List

The 5 NYSE Stocks With the Highest Short Interest in February

Merrill Lynch Dividend Yield Stocks to Buy

Jefferies 4 Top Pharmaceutical Stocks to Buy

The 4 Stocks That Lifted the DJIA on Tuesday

Top Analyst Upgrades and Downgrades: AbbVie, Alcoa, Apple, Deckers, Dish, Pfizer, Petrobras and More

The 4 Stocks That Dominated the DJIA on Thursday

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

Facebook Still a Small Company

Pfizer Faces Reality Check With Earnings

Merck Is Top DJIA Stock in 2015

The 4 Stocks That Weighed on the Market Tuesday

The Bullish and Bearish Case for Pfizer in 2015

The Bullish and Bearish Case for Johnson & Johnson in 2015

Forget Gold: For Retirees, This TIPS ETF Fights Inflation Better

UCOP: A 2X Bet on the Metal the World Can’t Electrify Without

After Comparing Every Covered Call Nasdaq-100 ETF These 3 Pay Up to 14 Percent Without Capping Your AI Upside

Featured Reads

Medicare Will Split Your $2,100 Drug Bill Into Monthly Installments. You Have to Ask First.

A 72-Year-Old Couple With $900,000 in IRAs Converts Nothing. Their Kids Inherit the Tax Bill Instead.